Skip to main content

Table 2 Demographic and Clinical Characteristics (SEER-Medicare, incident PCa cases ≥ 65 years old diagnosed during 1991-2002)

From: Lifetime economic burden of prostate cancer

Characteristic

Stage I

 

Stage II

 

Stage III

 

Stage IV

 

All

 

N, %

71,861

51.1%

25,590

18.2%

22,103

15.7%

21,011

14.9%

140,565

100.0%

Age at study index

          

   Mean (SD)

73.8

(5.8)

72.9

(5.8)

71.3

(5.3)

75.30

(7.2)

73.5

(6.1)

   Median

73

 

72

 

70

 

74

 

73

 

Age (5-year categories), N, %:

          

   65-69

18,974

26.4%

8,715

34.1%

9,738

44.1%

5,424

25.8%

42,851

30.5%

   70-74

22,922

31.9%

7,844

30.7%

7,378

33.4%

5,401

25.7%

43,545

31.0%

   75-79

18,140

25.2%

5,486

21.4%

3,230

14.6%

4,349

20.7%

31,205

22.2%

   80-84

8,235

11.5%

2,428

9.5%

1,177

5.3%

3,261

15.5%

15,101

10.7%

   85+

3,590

5.0%

1,117

4.4%

580

2.6%

2,576

12.3%

7,863

5.6%

Race, N, %:

          

   White

58,410

81.3%

20,674

80.8%

18,327

82.9%

15,873

75.6%

113,284

80.6%

   Black

7,448

10.4%

2,661

10.4%

1,839

8.3%

2,935

14.0%

14,883

10.6%

   Asian

2,572

3.6%

916

3.6%

807

3.7%

861

4.1%

5,073

3.6%

   Other

3,431

4.7%

1,339

5.2%

1,130

5.1%

1,342

6.3%

7,325

5.2%

Geographic region, N, %:

          

   Midwest

14,040

19.5%

4,531

17.7%

4,216

19.1%

4,357

20.7%

27,144

19.3%

   Northeast

12,303

17.1%

3,416

13.4%

2,041

9.2%

2,426

11.6%

20,186

14.4%

   South

7,024

9.8%

2,362

9.2%

1,566

7.1%

1,588

7.6%

12,540

8.9%

   West

38,494

53.6%

15,281

59.7%

14,280

64.6%

12,640

60.2%

80,695

57.4%

Predicted mean survival time (SD) in months

172

(85.9)

180.1

(95.8)

196.3

(107.0)

43.7

(39.1)

158.2

(99.2)

Mean survival time (SD) in months

          

   Initial

5.8

(1.1)

5.8

(1.1)

5.8

(1.1)

4.4

(2.5)

5.6

(1.5)

   Continuing

154.9

(85.0)

162.9

(95.1)

179.2

(106.2)

29.2

(36.5)

141.4

(98.0)

   Terminal

11.8

(1.2)

11.8

(1.1)

11.8

(1.7)

10.6

(3.1)

11.6

(1.7)

  1. N = Number of patients, SD = Standard deviation, SEER = Surveillance, Epidemiology, and End Results